Connecting the dots using gene-expression profiles.
Gullans
Steven R
SR
RxGen, New Haven, CT, USA.
D000544:Alzheimer Disease / Q000235:genetics; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002478:Cells, Cultured; D016208:Databases, Factual; D003907:Dexamethasone / Q000494:pharmacology / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D019008:Drug Resistance, Neoplasm; D015870:Gene Expression / Q000187:drug effects*; D020869:Gene Expression Profiling; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics; D020123:Sirolimus / Q000494:pharmacology / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003907:Dexamethasone; D020123:Sirolimus